Advertisement
Advertisement

GKOS

GKOS logo

Glaukos Corporation

143.67
USD
Sponsored
+26.71
+22.84%
Apr 30, 16:00 UTC -4
Closed
exchange

After-Market

142.71

-0.96
-0.67%

GKOS Earnings Reports

Positive Surprise Ratio

GKOS beat 29 of 42 last estimates.

69%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$147.71M
/
-$0.21
Implied change from Q1 26 (Revenue/ EPS)
-1.90%
/
+16.67%
Implied change from Q2 25 (Revenue/ EPS)
+19.00%
/
-12.50%

Glaukos Corporation earnings per share and revenue

On Apr 29, 2026, GKOS reported earnings of -0.18 USD per share (EPS) for Q1 26, beating the estimate of -0.27 USD, resulting in a 35.30% surprise. Revenue reached 150.57 million, compared to an expected 139.65 million, with a 7.82% difference. The market reacted with a +22.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 15 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 147.71 million USD, implying an increase of 16.67% EPS, and decrease of -1.90% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Integer Holdings Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$1.21
Actual
$1.20
Surprise
-0.84%
logo
Thermo Fisher Scientific, Inc.
Report Date
Apr 23, 2026 For Q1 26
Estimate
$5.28
Actual
$5.44
Surprise
+2.84%
logo
Intuitive Surgical Inc.
Report Date
Apr 21, 2026 For Q1 26
Estimate
$2.14
Actual
$2.50
Surprise
+16.77%
logo
Edwards Lifesciences Corp
Report Date
Apr 23, 2026 For Q1 26
Estimate
$0.74
Actual
$0.78
Surprise
+4.17%
logo
DexCom, Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.47
Actual
$0.56
Surprise
+17.03%
logo
Axogen, Inc. Common Stock
Report Date
Apr 28, 2026 For Q1 26
Estimate
$0.07
Actual
$0.07
Surprise
-4.50%
logo
PROCEPT BioRobotics Corporation Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.56
Actual
-$0.56
Surprise
+1.34%
logo
Opko Health Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+0.99%
logo
Beta Bionics, Inc. Common Stock
Report Date
Apr 21, 2026 For Q1 26
Estimate
-$0.49
Actual
-$0.49
Surprise
+1.69%
logo
OrthoPediatrics Corp. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.48
Actual
-$0.42
Surprise
+13.53%
FAQ
For Q1 2026, Glaukos Corporation reported EPS of -$0.18, beating estimates by 35.3%, and revenue of $150.57M, 7.82% above expectations.
The stock price moved up 22.84%, changed from $116.96 before the earnings release to $143.67 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 15 analysts, Glaukos Corporation is expected to report EPS of -$0.21 and revenue of $147.71M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement